These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 39111477)
1. Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches. Waqas M; Ullah S; Ullah A; Halim SA; Rehman NU; Khalid A; Ali A; Khan A; Gibbons S; Csuk R; Al-Harrasi A Int J Biol Macromol; 2024 Oct; 277(Pt 4):134476. PubMed ID: 39111477 [TBL] [Abstract][Full Text] [Related]
2. Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-cov-2 PLpro. Liu X; Zheng M; Zhang H; Feng B; Li J; Zhang Y; Zhang J; Zhao N; Li C; Song N; Song B; Yang D; Chen J; Qi A; Zhao L; Luo C; Zang Y; Liu H; Li J; Zhang B; Zhou Y; Zheng J Antiviral Res; 2024 Aug; 228():105944. PubMed ID: 38914283 [TBL] [Abstract][Full Text] [Related]
3. Exploring Cannabinoids as Potential Inhibitors of SARS-CoV-2 Papain-like Protease: Insights from Computational Analysis and Molecular Dynamics Simulations. Holmes J; Islam SM; Milligan KA Viruses; 2024 May; 16(6):. PubMed ID: 38932170 [TBL] [Abstract][Full Text] [Related]
4. Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2. Waqas M; Ullah S; Halim SA; Rehman NU; Ali A; Jan A; Muhsinah AB; Khan A; Al-Harrasi A Int J Biol Macromol; 2024 Feb; 258(Pt 1):128812. PubMed ID: 38114011 [TBL] [Abstract][Full Text] [Related]
5. A novel robust inhibitor of papain-like protease (PLpro) as a COVID-19 drug. Soleimani Asl S; Roozbahani MH J Biomol Struct Dyn; 2024 Aug; 42(13):6863-6870. PubMed ID: 37578047 [TBL] [Abstract][Full Text] [Related]
6. An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease. Samrat SK; Kumar P; Liu Y; Chen K; Lee H; Li Z; Chen Y; Li H Viruses; 2024 Aug; 16(8):. PubMed ID: 39205213 [TBL] [Abstract][Full Text] [Related]
7. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
8. Reconstruction of the unbinding pathways of new inhibitors of the SARS-CoV-2 papain-like protease using molecular dynamics simulation. Rahebi P; Aryapour H J Biomol Struct Dyn; 2024 Sep; 42(14):7501-7514. PubMed ID: 37505097 [TBL] [Abstract][Full Text] [Related]
9. Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro. Kiba Y; Tanikawa T; Kitamura M Biol Pharm Bull; 2024; 47(5):965-966. PubMed ID: 38763750 [TBL] [Abstract][Full Text] [Related]
10. Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity. Velma GR; Shen Z; Holberg C; Fu J; Soleymani F; Cooper L; Ramos OL; Indukuri D; Musku SR; Rychetsky P; Slilaty S; Li Z; Ratia K; Rong L; Schenten D; Xiong R; J Thatcher GR J Med Chem; 2024 Aug; 67(16):13681-13702. PubMed ID: 39102360 [TBL] [Abstract][Full Text] [Related]
11. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Shin D; Mukherjee R; Grewe D; Bojkova D; Baek K; Bhattacharya A; Schulz L; Widera M; Mehdipour AR; Tascher G; Geurink PP; Wilhelm A; van der Heden van Noort GJ; Ovaa H; Müller S; Knobeloch KP; Rajalingam K; Schulman BA; Cinatl J; Hummer G; Ciesek S; Dikic I Nature; 2020 Nov; 587(7835):657-662. PubMed ID: 32726803 [TBL] [Abstract][Full Text] [Related]
13. Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro. Lewis DSM; Ho J; Wills S; Kawall A; Sharma A; Chavada K; Ebert MCCJC; Evoli S; Singh A; Rayalam S; Mody V; Taval S Sci Rep; 2022 Feb; 12(1):2145. PubMed ID: 35140265 [TBL] [Abstract][Full Text] [Related]
14. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease. Choudhary S; Nehul S; Singh A; Panda PK; Kumar P; Sharma GK; Tomar S IUBMB Life; 2024 May; 76(5):228-241. PubMed ID: 38059400 [TBL] [Abstract][Full Text] [Related]
15. Native Mass Spectrometry Reveals Binding Interactions of SARS-CoV-2 PLpro with Inhibitors and Cellular Targets. James VK; Godula RN; Perez JM; Beckham JT; Butalewicz JP; Sipe SN; Huibregtse JM; Brodbelt JS ACS Infect Dis; 2024 Oct; 10(10):3597-3606. PubMed ID: 39303064 [TBL] [Abstract][Full Text] [Related]
16. Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease. Mirza MU; Ahmad S; Abdullah I; Froeyen M Comput Biol Chem; 2020 Dec; 89():107376. PubMed ID: 32979815 [TBL] [Abstract][Full Text] [Related]
18. Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors. Freire MCLC; Noske GD; Bitencourt NV; Sanches PRS; Santos-Filho NA; Gawriljuk VO; de Souza EP; Nogueira VHR; de Godoy MO; Nakamura AM; Fernandes RS; Godoy AS; Juliano MA; Peres BM; Barbosa CG; Moraes CB; Freitas-Junior LHG; Cilli EM; Guido RVC; Oliva G Molecules; 2021 Aug; 26(16):. PubMed ID: 34443484 [TBL] [Abstract][Full Text] [Related]
19. Molecular modelling on SARS-CoV-2 papain-like protease: an integrated study with homology modelling, molecular docking, and molecular dynamics simulations. Arwansyah A; Arif AR; Ramli I; Kurniawan I; Sukarti S; Nur Alam M; Illing I; Farid Lewa A; Manguntungi B SAR QSAR Environ Res; 2021 Sep; 32(9):699-718. PubMed ID: 34392751 [TBL] [Abstract][Full Text] [Related]
20. Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations. Zrieq R; Ahmad I; Snoussi M; Noumi E; Iriti M; Algahtani FD; Patel H; Saeed M; Tasleem M; Sulaiman S; Aouadi K; Kadri A Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]